These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38445620)

  • 1. Elucidating the role of
    Jiang L; Yang D; Zhang Z; Xu L; Jiang Q; Tong Y; Zheng L
    Pharm Biol; 2024 Dec; 62(1):272-284. PubMed ID: 38445620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exploring the treatment of sepsis-associated acute lung injury with Liangge Powder via ERK1/2 and PI3K/AKT pathways: based on network pharmacology and whole animal experimentation].
    Huang R; He WJ; Zhang PP; Wang DQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Feb; 41(2):94-103. PubMed ID: 36882272
    [No Abstract]   [Full Text] [Related]  

  • 3. The protective effect of ginsenoside Rg1 against sepsis-induced lung injury through PI3K-Akt pathway: insights from molecular dynamics simulation and experimental validation.
    Zhong K; Huang Y; Chen R; Pan Q; Li J; Xi X
    Sci Rep; 2024 Jul; 14(1):16071. PubMed ID: 38992150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Songorine inhibits oxidative stress-related inflammation through PI3K/AKT/NRF2 signaling pathway to alleviate lipopolysaccharide-induced septic acute lung injury.
    Fang J; Huang Q; Shi C; Gai L; Wang X; Yan B
    Immunopharmacol Immunotoxicol; 2024 Apr; 46(2):152-160. PubMed ID: 37977206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
    Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
    Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying the synergistic effects of chuanxiong combined with Chishao on treating acute lung injury based on network pharmacology and molecular docking combined with preclinical evaluation.
    Gao J; Wang N; Song W; Yuan Y; Teng Y; Liu Z
    J Ethnopharmacol; 2024 May; 325():117862. PubMed ID: 38342157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Rhodiola rosea-Euonymus alatus drug pair against rheumatoid arthritis: Network pharmacology and experimental validation.
    Zheng QH; Du LY; Zhao Y; Zhang Z; Piao SL; Wang YH; Pan Z
    Immun Inflamm Dis; 2023 Dec; 11(12):e1127. PubMed ID: 38156377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
    J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
    Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
    J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of Wenqingyin on sepsis-induced acute lung injury through regulation of the receptor for advanced glycation end products pathway.
    Xie L; Zhang G; Wu Y; Hua Y; Ding W; Han X; Liu B; Zhou C; Li A
    Phytomedicine; 2024 Jul; 129():155654. PubMed ID: 38723525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae.
    Ding Z; Zhong R; Yang Y; Xia T; Wang W; Wang Y; Xing N; Luo Y; Li S; Shang L; Shu Z
    Pharmacol Res; 2020 Jun; 156():104759. PubMed ID: 32200026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRPK1 promotes sepsis-induced acute lung injury via regulating PI3K/AKT/FOXO3 signaling.
    Guo W; Hu Z
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):203-212. PubMed ID: 36226860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huashibaidu formula attenuates sepsis-induced acute lung injury via suppressing cytokine storm: Implications for treatment of COVID-19.
    Zhang F; Guo F; Zhang Y; Xu H; Liu Y; Lin L; Li H; Yang H; Huang L
    Phytomedicine; 2023 Jan; 109():154549. PubMed ID: 36610129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shenfu injection targets the PI3K-AKT pathway to regulate autophagy and apoptosis in acute respiratory distress syndrome caused by sepsis.
    Chen J; Ding W; Zhang Z; Li Q; Wang M; Feng J; Zhang W; Cao L; Ji X; Nie S; Sun Z
    Phytomedicine; 2024 Jul; 129():155627. PubMed ID: 38696924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QiShenYiQi pills preserve endothelial barrier integrity to mitigate sepsis-induced acute lung injury by inhibiting ferroptosis.
    Li Z; Yu Y; Bu Y; Liu C; Jin J; Li W; Chen G; Liu E; Zhang Y; Gong W; Luo J; Yue Z
    J Ethnopharmacol; 2024 Mar; 322():117610. PubMed ID: 38122915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate ameliorates sepsis-induced acute lung injury by activating the mTOR/AKT/PI3K axis.
    Zhang E; Wang J; Chen Q; Wang Z; Li D; Jiang N; Ju X
    Gene; 2020 Oct; 759():144969. PubMed ID: 32712064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penehyclidine hydrochloride protects against lipopolysaccharide-induced acute lung injury by promoting the PI3K/Akt pathway.
    Weng J; Liu D; Shi B; Chen M; Weng S; Guo R; Fu C
    Int J Immunopathol Pharmacol; 2023; 37():3946320231192175. PubMed ID: 37500500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRC3 Participates in Inhibiting the Pulmonary Inflammatory Response of Sepsis-Induced Acute Lung Injury.
    Li R; Zhao Y; Zhang X; Yang L; Zou X
    Immunol Invest; 2023 Nov; 52(5):567-582. PubMed ID: 37139806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/Akt pathway-mediated HO-1 induction regulates mitochondrial quality control and attenuates endotoxin-induced acute lung injury.
    Shi J; Yu J; Zhang Y; Wu L; Dong S; Wu L; Wu L; Du S; Zhang Y; Ma D
    Lab Invest; 2019 Dec; 99(12):1795-1809. PubMed ID: 31570770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.